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Abstract
Background: The use of contact lenses has increased in recent years as has the incidence of Dry Eye Syndrome,
partly due to their use. Artificial tears are the most common treatment option. Since these changes can facilitate
Acanthamoeba infection, the present study has been designed to evaluate the effect of three artificial tears
treatments in the viability of Acanthamoeba genotype T4 trophozoites. Optava Fusion™, Oculotect®, and Artelac®
Splash were selected due to their formulation.
Methods: Viability was assessed using two staining methods, Trypan Blue stain and CTC stain at different time
intervals (2, 4, 6, 8 and 24 h). Trypan Blue viability was obtained by manual count with light microscopy while the
CTC stain was determined using flow cytometry.
Results: Trypan Blue staining results demonstrated a decrease in viability for Optava Fusion™ and Artelac® Splash
during the first 4 h of incubation. After, this effect seems to lose strength. In the case of Oculotect®, complete cell
death was observed after 2 h. Using flow cytometry analysis, Optava Fusion™ and Oculotect® exhibited the same
effect observed with Trypan Blue staining. However, Artelac® Splash revealed decreasing cell respiratory activity after
four hours, with no damage to the cell membrane.
Conclusions: The present study uses, for the first time, CTC stain analyzed by flow cytometry to establish Acanthamoeba
viability demonstrating its usefulness and complementarity with the traditional stain, Trypan Blue. Artelac® Splash, with no
preservatives, and Optava Fusion TM, with Purite®, have not shown any useful amoebicidal activity. On the contrary,
promising results presented by Ocultect®, with BAK, open up a new possibility for Acanthamoeba keratitis prophylaxis and
treatment although in vivo studies should be carried out.
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Background
Acanthamoeba spp. are one of the most commonly
isolated amoebae in environmental samples.They have
a cosmopolitan distribution and can act as both
opportunistic and non-opportunistic pathogens [1].
These amoebae have been isolated from soil, dust, air,
seawater, swimming pools, sewage, sediments, air-
conditioning units, domestic tap water, bottled water,
dental treatment units, hospitals, dialysis apparatus,
eyewash stations, contact lenses and their cases and
as contaminants in bacterial, yeast and mammalian
cell cultures [2, 3]. Acanthamoeba species present two
morphological stages in their life-cycle: a vegetative
trophozoite stage, in which they are active and
reproduce by binary fission, and a cyst stage that is
resistant to environmentally adverse conditions [4, 5].
These free-living amoebae are typically harmless to
humans, but in rare instances can cause severe infec-
tions. One of these infections, Acanthamoeba keratitis
(AK), is an ulceration of the cornea which, if not treated
promptly, can cause extensive ocular damage, leading to
loss of vision acuity, blindness and possible enucleation
[4, 6–8].
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In recent decades, there has been a remarkable rise
in the number of diagnosed AK cases, mostly due to
an increase in the number of contact lens (CL)
wearers [9, 10]. Most of these cases affect immuno-
competent CL wearers and result from poor hygiene
practices as well as the failure to comply with rec-
ommended cleaning and disinfection procedures,
rinsing with tap water or homemade saline solutions,
showering while wearing lenses and the extended
use of disposable CL [11].
Contact lenses wear alone is frequently associated
with symptoms of ocular irritation, including dryness,
discomfort, soreness and tiredness [12]. Sometimes
these signs of ocular surface impairment resemble dry
eye conditions in non-lens wearers. Dry eye syndrome
(DES) is a disorder of the tear film due to tear defi-
ciency or excessive tear evaporation, which can cause
damage to the interpalpebral ocular surface. It is also
associated with symptoms of ocular discomfort, and
contact lens dry eye is considered a sub-classification
of this syndrome [13, 14].
The sole presence of a CL on the eye affects the
nature of tear film dispersal. A reduction in the pre-
lens tear film lipid layer and an increase in tear film
evaporation are attributed to CL wear, resulting in
the onset of dryness. Additionally, the disruption of
the tear film by the CL may lead to compromised
functional visual acuities, reduced wear time, and an
increased risk of ocular surface desiccation, bacterial
binding and infection [12]. These alterations in the
corneal epithelium produced both by DES and CL
wear, can create a possible entry point for ocular sur-
face invasion [15]. For example, several in vivo studies
indicate that corneal trauma is a prerequisite for AK,
as animals with intact corneas (i.e. epithelial cells) do
not develop this infection [5].
For the treatment of these symptoms, rewetting
drops are traditionally the most common first-line
option. However, technological advances have led to
the development of artificial tear solutions, also
known as lubricant eye drops, which mimic the tear
film function and protect the ocular surface from
dryness. Recently, several artificial tear solutions have
been produced to reduce these symptoms. They
account for at least $540 million in annual sales glo-
bally and are currently the mainstay of therapy of
DES due to their noninvasive nature and reduced side
effect profile [12, 16, 17].
Moreover, these artificial tears are formulated with
different preservative compounds that may present use-
ful properties in preventing ocular infections. In this
study, the potential amoebicidal effects of artificial tear
solutions were evaluated for the first time in order to
establish their usefulness in the prevention of AK.
Methods
Acanthamoeba culture
Acanthamoeba spp. strain USP-CR5-A35 genotype T4,
which was originaly isolated form a Spanish keratitits
patient, was used to study the effect of the artificial tears
analyzed [18]. Axenic cultures were grown in PYG
medium (0.75% protease peptone, 0.75% yeast extract
and 1.5% glucose with 40 μg gentamicin per milliliter) at
28 °C without shaking. After 24 h of culture, the culture
flask was incubated on ice for 5 min to favor amoebae
de-attachment and then trophozoites were collected
with the help of a pipette, washed twice with NEFF sa-
line [19] and the concentration was adjusted in NEFF to
4 × 105 amoebae/ml.
Tested artificial tears
Three different commercially available artificial tears
were chosen for this study due to the different types
of preservatives (detergent or oxidative) or the lack of
them (Artelac® Splash, Bausch & Lomb, Berlin,
Germany) in their formulation. Characteristics of the
different tears are shown in Table 1. Benzalkonium
chloride (BAK) which interrupts the lipid component
of cell membranes acting as an antibiotic and amoebi-
cidal) is a detergent found in Oculotect® (Laboratoires
Alcon, Kaysersberg, France) [20]. Purite® (Allergan,
Westport, Ireland) is a stabilized oxychloride complex
with chlorine dioxide, chlorite and chlorate found in
Optava Fusion™ (Allergan, Westport, Ireland). When
excited by light, they produce water, oxygen, sodium,
and chlorine free radicals. These radicals interact with
the pathogen membrane causing death. To our
knowledge, Purite® has never been tested for
Acanthamoeba.
Effect of artificial tears against Acanthamoeba, culture
and microscopic observation
In T25 culture bottles, 2.5 ml of the amoebae suspen-
sion (USP-CR5-A45 at 4 × 105 amoebae/ml) was cul-
tured with 2.5 ml of the artificial tears. Non-effect
control was performed with NEFF saline. These
cultures were incubated at 33 °C for 2 h, 4 h, 6 h
and 8 h as previously described [20–22]. Before cul-
ture collection, the appearance of the Acanthamoeba
trophozoites was checked under light microscopy at
400× (Nikon Eclipse TS100, Nikon Instruments
Europe B.V.). Cultures were collected and washed
with PBS by centrifugation at 1500× rpm for 10 min.
After, amoebae were suspended in 1 ml of PBS and
divided into two aliquots for the viability test. Culture
with the artificial tears was performed in triplicate for
the four different incubation times.
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Viability tests
Trypan blue stain
Trypan Blue 0.4% (BioWhittaker®, Walkersville, USA)
was used 1:1 with the amoebae suspension to establish
Acanthamoeba viability after incubation with the differ-
ent tears. Trypan Blue is a vital stain that colors only
dead cells. Living amoebae have a refringent appearance
under light microscopy while dead amoebae exhibit a
blue color. Cells were counted using a BRAND®
counting chamber BLAUBRAND® Neubauer pattern
(Sigma-Aldrich, Merck KGaA, Darmstadt, Germany).
Flow cytometry
To establish Acanthamoeba viability, Bacstain-CTC
Rapid Staining Kit (Dojindo,Kumamoto, Japan) was used
to stain viable amoebae. CTC (5-cyano-2,3-ditolyl-tetra-
zolium chloride) is a stain used to measure bacterial via-
bility. CTC is a soluble reagent which, when it interacts
with the respiratory system, gains a proton and becomes
an insoluble product, CTC formazan. This product is
fluorescent, a characteristic that allows it to be used in
flow cytometry. Kobayashi et al. [23] first described the
use of this product for Acanthamoeba viability in a
fluorometric assay.
Amoebae were cultured with CTC for 30 min and
then washed and fixed with PBS-1% formalin. Parasites
were identified based on forward/side scatter values and
a total of 10,000 events was obtained by FACScalibur
cytometer using the CELLquest software. The fluores-
cence was evaluated in FL3 histograms. Cytometer files




Cultures were observed using an inverted microscope at
× 400 magnification before the amoebae were collected.
As shown in Fig. 1 morphological changes were ob-
served after 8 h. Amoebae in NEFF saline solution as
well as in Artelac® Splash presented the typical amoebae
Table 1 Characteristics of the artificial tears studied and cytometry results are shown as viability percentage
Components Preservative % viability (TB); % viability (CTC); % altered
morphology (CTC)
2 h 4 h 6 h 8 h
Oculotect® 50 mg/ml
(Novartis)
Povidone K25; sodium hidroxide Benzalkonium
chloride (BAK)
3.6; 4.9; 0 1.8; 7.3; 0 5.5; 1.5; 0 2.5; 4.1; 0
Optava Fusion™
(Allergan)






















Fig. 1 Acanthamoeba culture appearance at 4, 6 and 8 h of incubation with the studied artificial tears. Scale-bars: 100 μm
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morphology attached to the culture flask with acantho-
podia projecting and vacuolated cytoplasm, while amoe-
bae in Optava Fusion™ were detached and rounded. In
the culture bottle containing Oculotect®, only cellular
debris was observed (Fig. 1).
Viability tests
Trypan blue stain
Viability studied using Trypan Blue showed a decrease
in the case of Optava Fusion™ and Artelac® Splash after
the first 4 h. Nevertheless, after 8 h, recuperation of the
amoebae was observed in both tears, amoebae concen-
tration being similar to that of the NEFF control. In the
case of Oculotect® Acanthamoeba trophozoites were not
detected after 2 h of incubation.
Flow cytometry
The flow cytometric analyses identified one population
of parasites based on forward/side scatter values (R1)
(Fig. 2). A second population of altered smaller tropho-
zoites, R2, was observed after incubation with the artifi-
cial tears (Fig. 2), except for Oculotect® incubation
where only an R1 population was observed for all the
incubation times tested. After gating on the basis of
forward/side scatter values, the quantification of the
relative fluorescence intensity was determined for both
populations of each sample. Based on the histogram
representing the viability of standard trophozoites, an
area (M1) was determined for the measurement of the
percentage fluorescent amoebae in all samples. For the
NEFF control, the percentage of viable amoebae
decreased from 74.9% to 45.6% in 8 h (Table 1). After
two hours’ treatment with Artelac® Splash and Optava
Fusion™ a reduction of the viable population in R1 to
58.8 and 44.5% respectively, was observed. After 8 h, via-
bility was 10.8 and 31.0%, respectively, which means a
4.22-fold and 1.47-fold increase with regard to NEFF.
The percentage population of amoebae in R2 increased
from 3.3 to 10.9% in 8 h for Artelac® Splash, and from
16.6 to 28.8% for Optava Fusion™. Treatment with Ocu-
lotect® for 2 h reduced the population of fluorescent
amoebae to 4.9%, 15.35-times with regard to NEFF. The
effect of Oculotect® was constant from the beginning
and the percentage of viable amoebae remained similar
at 8 h of incubation (4.1%) (Table 1).
Discussion
In the present study, three artificial tear brands were
selected according to the preservative agents (detergent
or oxidative) or the lack of them to study their possible
amoebicidal activity against trophozoites, as this is the
initial state of the infection.
To study the viability of Acanthamoeba trophozoites
after incubation with these tears, two different methods
were used. The more traditional one, Trypan Blue stain,
allows the differentiation of amoebae with the altered
cell membrane and thus, identification of the non-viable
ones. The second method used CTC stain to measure
mitochondrial activity to determine the viability of the
amoebae. This stain was developed for bacterial viability
and then, adapted for Acanthamoeba in fluorometry by
Kobayashi et al. [23]. In the present study, CTC stain for
Acanthamoeba viability was used with flow cytometry
for the first time.
One of the artificial tears tested using these two
methods was Optava Fusion™. It contains Purite®, which
is a soft oxidative preservative agent with demonstrated
antimicrobial activity (bacteria, viruses and fungi), which
dissociates on the eye surface in a photolytic reaction
[24]. Contact of Acanthamoeba trophozoites with this
artificial tear produced a slight decrease in the
mitochondrial activity of amoebic cells (R1) during the
incubation interval. However, a population of morpho-
logically altered amoebae was observed which increased
to 28.8% after eight hours (R2). If viability is considered
as the sum of the two morphologies, results were similar
to those obtained with Trypan Blue stain. In conse-
quence, evaluation of both parameters, membrane integ-
rity, and cell respiratory activity, seems to be crucial in
the evaluation of the effectiveness of artificial tears and
potential anti-amoebic compounds.
A further artificial tear evaluated was Artelac® Splash,
whose formula does not contain any preservatives. Ana-
lysis of this artificial tear with Trypan Blue staining
seemed to produce the same effect as the one observed
in the presence of Optava Fusion™, demonstrating an ap-
parent decrease in amoebae viability after two hours but
a discrete increase for longer periods. However, analysis
with flow cytometry and CTC staining revealed decreas-
ing cell respiratory activity in the studied time intervals
without morphological change (R1 and R2). Additionally,
both Optava Fusion™ and Artelac® Splash contain so-
dium hyaluronate in their composition, a salt that has
been proved to be a stimulator of proliferation of the
corneal epithelium [25], so it could be also stimulating
amoebic growth.
In the case of the artificial tear Oculotect®, the preser-
vative agent used is BAK, a known antibiotic and
amoebicidal compound [20]. This study demonstrated
that BAK, in its commercially available formulation,
maintains good amoebicidal activity despite the other
components of the artificial tear and even when the tear
is diluted 1:1. This amoebicidal effect was observed from
the first hours of incubation and it maintained its effec-
tiveness during all the time intervals evaluated with both
viability techniques used. A decrease in the number of
amoebic cells with Trypan Blue and low mitochondrial
activity was observed using CTC.
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In view of these results, we must highlight the impor-
tance of the data obtained with both methods used to
investigate the viability of Acanthamoeba trophozoites.
Trypan Blue staining and flow cytometry provide quite
similar information for viability analysis, but they evalu-
ate different characteristics, in such a way that the data
they reveal are not exclusionary but complementary. As
was observed with Artelac® Splash, some cells can
diminish their mitochondrial activity gradually while
maintaining the integrity of the plasmatic membrane, a
characteristic that can be interpreted differently by these
two methods if they are used separately. Our results
Fig. 2 Histogram statistic of the CTC viability assay of Artelac® Splash, Optava Fusion™, Oculotect® and NEFF by flow cytometry at 2 h, 4 h, 6 h
and 8 h incubation. R1: normal amoebae population; R2: altered smaller amoebae trophozoites
Magnet et al. Parasites & Vectors  (2018) 11:50 Page 5 of 7
demonstrate that conventional viability staining with
Trypan Blue is a useful method. Nevertheless, flow
cytometry analysis with CTC staining can be helpful in
eliminating observer bias due to its automated feature
and this prevents possible misevaluations caused by
overexposure to Trypan Blue.
Finally, in this study, only Oculotect® was demon-
strated to have an important and durable amoebicidal
effect on Acanthamoeba trophozoites. However, we
must be aware of the possible surface toxicity that BAK
can produce on the cornea epithelium with frequent or
extended use. This characteristic means that it is not ad-
visable to use this artificial tear concomitantly with soft
lenses. Hard contact lenses adsorb a small amount of
this preservative and release a significant percentage of
it during a regular washout procedure, approaching the
upper safety limit, but soft contact lenses present a high
adsorption of this substance. Such a property could
allow the accumulation of BAK in the cornea epithelium,
producing adverse effects [20]. Despite BAK’s toxicity,
the promising results showed by Oculotect®, its use as a
PrEP (pre-exposure prophylaxis) strategy before eye
surgery should be considered. Nevertheless, studies in
corneal models or even in patients are needed to estab-
lish the in vivo amoebicidal effect of this kind of artificial
tear formulation.
Conclusions
To our knowledge, the present study uses for the first time
CTC stain analyzed by flow cytometry to establish
Acanthamoeba viability demonstrating its usefulness and
complementarity with the traditional stain, Trypan Blue.
Artelac® Splash, with no preservatives, and Optava
Fusion™, with Purite®, have not shown any amoebicidal
activity. On the contrary, promising results shown by
Ocultect®, with BAK, open up a new possibility of Acanth-
amoeba keratitis prophylaxis and treatment, although in
vivo studies should be carried out.
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